• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Skin tests in urticaria/angioedema and flushing to Pfizer-BioNTech SARS-CoV-2 vaccine: Limits of intradermal testing.

作者信息

Bianchi Leonardo, Biondi Filippo, Hansel Katharina, Murgia Nicola, Tramontana Marta, Stingeni Luca

机构信息

Department of Medicine and Surgery, Section of Dermatology, University of Perugia, Perugia, Italy.

Department of Medicine and Surgery, Section of Occupational Medicine, Respiratory Diseases and Toxicology, University of Perugia, Perugia, Italy.

出版信息

Allergy. 2021 Aug;76(8):2605-2607. doi: 10.1111/all.14839. Epub 2021 Apr 22.

DOI:10.1111/all.14839
PMID:33811344
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8251329/
Abstract
摘要

相似文献

1
Skin tests in urticaria/angioedema and flushing to Pfizer-BioNTech SARS-CoV-2 vaccine: Limits of intradermal testing.荨麻疹/血管性水肿及辉瑞-生物科技公司新冠病毒疫苗引起的潮红反应中的皮肤试验：皮内试验的局限性
Allergy. 2021 Aug;76(8):2605-2607. doi: 10.1111/all.14839. Epub 2021 Apr 22.
2
COVID-19 vaccines: comparison of biological, pharmacological characteristics and adverse effects of Pfizer/BioNTech and Moderna Vaccines.COVID-19 疫苗：辉瑞/生物科技和 Moderna 疫苗的生物学、药理学特征和不良反应比较。
Eur Rev Med Pharmacol Sci. 2021 Feb;25(3):1663-1669. doi: 10.26355/eurrev_202102_24877.
3
Cutaneous reactions after COVID-19 vaccination in Turkey: A multicenter study.土耳其 COVID-19 疫苗接种后的皮肤反应：一项多中心研究。
J Cosmet Dermatol. 2022 Sep;21(9):3692-3703. doi: 10.1111/jocd.15209. Epub 2022 Jul 19.
4
The effectiveness of single and two-dose Pfizer-BioNTech vaccine against SARS-COV-2: A real-world evidence from Saudi Arabia.辉瑞-生物科技单剂和两剂疫苗对 SARS-COV-2 的有效性：来自沙特阿拉伯的真实世界证据。
J Infect Public Health. 2023 Dec;16(12):1898-1903. doi: 10.1016/j.jiph.2023.09.014. Epub 2023 Sep 28.
5
Quantitative SARS-CoV-2 anti-spike responses to Pfizer-BioNTech and Oxford-AstraZeneca vaccines by previous infection status.根据既往感染状况，定量检测辉瑞-生物科技和牛津-阿斯利康疫苗对 SARS-CoV-2 刺突蛋白的抗体反应。
Clin Microbiol Infect. 2021 Oct;27(10):1516.e7-1516.e14. doi: 10.1016/j.cmi.2021.05.041. Epub 2021 Jun 7.
6
[Comparative Analyses of IgA Antibody Response of Non-COVID-19 Infected People Over 60 Years Old Following CoronaVac and Pfizer-BioNTech COVID-19 Vaccination].60岁以上未感染新冠病毒人群接种科兴新冠疫苗和辉瑞-BioNTech新冠疫苗后IgA抗体反应的比较分析
Mikrobiyol Bul. 2023 Apr;57(2):330-333. doi: 10.5578/mb.20239927.
7
[Efficacy of Homologous and Heterologous Vaccine Applications on SARS-CoV-2 Omicron Variant: Cohort of Manisa Celal Bayar University Healthcare Workers].[同源和异源疫苗接种对严重急性呼吸综合征冠状病毒2奥密克戎变异株的效果：马尼萨杰拉尔·拜亚尔大学医护人员队列研究]
Mikrobiyol Bul. 2023 Apr;57(2):238-251. doi: 10.5578/mb.20239918.
8
Humoral and cellular response of two different vaccines against SARS-CoV-2 in a group of healthcare workers: An observational study.两种不同 SARS-CoV-2 疫苗在一组医护人员中的体液和细胞免疫反应：一项观察性研究。
J Immunol Methods. 2024 May;528:113665. doi: 10.1016/j.jim.2024.113665. Epub 2024 Mar 14.
9
Sweet syndrome induced by SARS-CoV-2 Pfizer-BioNTech mRNA vaccine.由新冠病毒辉瑞-BioNTech信使核糖核酸疫苗诱发的Sweet综合征。
Allergy. 2021 Oct;76(10):3194-3196. doi: 10.1111/all.14981. Epub 2021 Jul 3.
10
Comment on "Caution against injudicious vaccine allergy skin test and adverse reactions after intradermal COVID-19 vaccine testing".对《谨防新冠病毒疫苗皮内试验时不当的疫苗过敏皮肤试验及不良反应》的评论
Contact Dermatitis. 2022 Mar;86(3):237. doi: 10.1111/cod.14014. Epub 2021 Dec 1.

引用本文的文献

1
The Impact of COVID-19 Vaccination on Inflammatory Skin Disorders and Other Cutaneous Diseases: A Review of the Published Literature.COVID-19 疫苗接种对炎症性皮肤疾病和其他皮肤疾病的影响：已发表文献综述。
Viruses. 2023 Jun 23;15(7):1423. doi: 10.3390/v15071423.
2
The role of lymphocyte transformation tests (LTT) in suspected severe delayed hypersensitivity reactions following COVID-19 vaccination.淋巴细胞转化试验（LTT）在疑似 COVID-19 疫苗接种后严重迟发性超敏反应中的作用。
Hum Vaccin Immunother. 2023 Dec 31;19(1):2182527. doi: 10.1080/21645515.2023.2182527. Epub 2023 Mar 13.
3
Study of Excipients in Delayed Skin Reactions to mRNA Vaccines: Positive Delayed Intradermal Reactions to Polyethylene Glycol Provide New Insights for COVID-19 Arm.mRNA疫苗延迟皮肤反应中辅料的研究：对聚乙二醇的阳性延迟皮内反应为新冠疫苗接种部位反应提供新见解
Vaccines (Basel). 2022 Nov 30;10(12):2048. doi: 10.3390/vaccines10122048.
4
Late Hypersensitivity Reactions to the BNT162b2 SARS-CoV-2 Vaccine Are Linked to Delayed Skin Sensitization and Prior Exposure to Hyaluronic Acid.对BNT162b2新型冠状病毒疫苗的迟发型超敏反应与延迟皮肤致敏和先前接触透明质酸有关。
Life (Basel). 2022 Dec 3;12(12):2021. doi: 10.3390/life12122021.
5
Cutaneous Reactions Following COVID-19 Vaccination: A Review of the Current Literature.新冠疫苗接种后的皮肤反应：当前文献综述
Clin Cosmet Investig Dermatol. 2022 Nov 6;15:2369-2382. doi: 10.2147/CCID.S388245. eCollection 2022.
6
SARS-CoV-2 Infection and Vaccination Cutaneous Manifestations for the Inpatient Dermatologist.住院皮肤科医生需了解的新型冠状病毒2型感染与疫苗接种的皮肤表现
Curr Dermatol Rep. 2022;11(4):252-262. doi: 10.1007/s13671-022-00374-5. Epub 2022 Oct 19.
7
Delayed urticaria after BNT162b2 booster vaccination at previous intradermal test site with severe acute respiratory syndrome-coronavirus-2 spike protein.在先前进行严重急性呼吸综合征冠状病毒2刺突蛋白皮内试验的部位接种BNT162b2加强疫苗后出现迟发性荨麻疹。
Asia Pac Allergy. 2022 Jul 18;12(3):e27. doi: 10.5415/apallergy.2022.12.e27. eCollection 2022 Jul.
8
Immediate Hypersensitivity Reactions Induced by COVID-19 Vaccines: Current Trends, Potential Mechanisms and Prevention Strategies.新型冠状病毒肺炎疫苗引起的速发型超敏反应：当前趋势、潜在机制及预防策略
Biomedicines. 2022 May 28;10(6):1260. doi: 10.3390/biomedicines10061260.
9
Serum polyethylene glycol-specific IgE and IgG in patients with hypersensitivity to COVID-19 mRNA vaccines.对 COVID-19 mRNA 疫苗过敏患者的血清聚乙二醇特异性 IgE 和 IgG。
Allergol Int. 2022 Oct;71(4):512-519. doi: 10.1016/j.alit.2022.05.007. Epub 2022 Jun 6.
10
Allergological study in patients vaccinated against COVID-19 with suspected allergic reactions.对接种新冠疫苗后出现疑似过敏反应患者的变态反应学研究。
Allergy Asthma Clin Immunol. 2022 May 27;18(1):43. doi: 10.1186/s13223-022-00685-z.

本文引用的文献

1
Practical recommendations for the allergological risk assessment of the COVID-19 vaccination - a harmonized statement of allergy centers in Germany.2019冠状病毒病疫苗过敏风险评估的实用建议——德国过敏中心的统一声明
Allergol Select. 2021 Jan 26;5:72-76. doi: 10.5414/ALX02225E. eCollection 2021.
2
Allergic Reactions Including Anaphylaxis After Receipt of the First Dose of Pfizer-BioNTech COVID-19 Vaccine.接种辉瑞-生物科技公司新冠疫苗第一剂后包括过敏反应在内的过敏反应。
JAMA. 2021 Feb 23;325(8):780-781. doi: 10.1001/jama.2021.0600.
3
EAACI statement on the diagnosis, management and prevention of severe allergic reactions to COVID-19 vaccines.欧洲过敏与临床免疫学会关于严重 COVID-19 疫苗过敏反应的诊断、管理和预防的声明
Allergy. 2021 Jun;76(6):1629-1639. doi: 10.1111/all.14739.
4
Excipients as Potential Agents of Anaphylaxis in Vaccines: Analyzing the Formulations of Currently Authorized COVID-19 Vaccines.疫苗中作为潜在过敏反应介质的辅料：分析当前获批的新冠疫苗配方
J Investig Allergol Clin Immunol. 2021 Feb 17;31(1):92-93. doi: 10.18176/jiaci.0667. Epub 2020 Jan 12.
5
Skin tests in the diagnosis of adverse drug reactions.皮肤试验在药物不良反应诊断中的应用。
G Ital Dermatol Venereol. 2020 Oct;155(5):602-621. doi: 10.23736/S0392-0488.20.06698-5. Epub 2020 Sep 17.
6
Skin test concentrations for systemically administered drugs -- an ENDA/EAACI Drug Allergy Interest Group position paper.皮下注射药物的浓度——ENDA/EAACI 药物过敏兴趣小组立场文件。
Allergy. 2013 Jun;68(6):702-12. doi: 10.1111/all.12142. Epub 2013 Apr 25.